{"id":"https://openalex.org/W2099475302","doi":"https://doi.org/10.1128/aac.00717-12","title":"Small-Molecule Inhibitors of the LEDGF/p75 Binding Site of Integrase Block HIV Replication and Modulate Integrase Multimerization","display_name":"Small-Molecule Inhibitors of the LEDGF/p75 Binding Site of Integrase Block HIV Replication and Modulate Integrase Multimerization","alternate_titles":[],"publication_year":2012,"publication_date":"2012-06-05","ids":{"openalex":"https://openalex.org/W2099475302","doi":"https://doi.org/10.1128/aac.00717-12","mag":"2099475302","pmid":"https://pubmed.ncbi.nlm.nih.gov/22664975","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3421592"},"language":"en","primary_location":{"id":"doi:10.1128/aac.00717-12","doi":"https://doi.org/10.1128/aac.00717-12","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.00717-12","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2099475302"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://europepmc.org/articles/PMC3421592","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036165439","display_name":"Frauke Christ","orcid":"https://orcid.org/0000-0001-9580-3874","observed_orcids":["https://orcid.org/0000-0001-9580-3874"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Frauke Christ","raw_affiliation_strings":["Katholieke Universiteit Leuven, Molecular Virology and Gene Therapy (VCTB+5), Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Katholieke Universiteit Leuven, Molecular Virology and Gene Therapy (VCTB+5), Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112166133","display_name":"Stephen Michael Shaw","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189718659","display_name":"Pfizer (United Kingdom)","ror":"https://ror.org/04x4v8p40","country_code":"GB","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I189718659"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Stephen Shaw","raw_affiliation_strings":["Pfizer Ltd., Sandwich, Kent, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Ltd., Sandwich, Kent, United Kingdom","institution_ids":["https://openalex.org/I189718659"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021604609","display_name":"Jonas Demeulemeester","orcid":"https://orcid.org/0000-0002-2660-2478","observed_orcids":["https://orcid.org/0000-0002-2660-2478"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Jonas Demeulemeester","raw_affiliation_strings":["Katholieke Universiteit Leuven, Molecular Virology and Gene Therapy (VCTB+5), Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Katholieke Universiteit Leuven, Molecular Virology and Gene Therapy (VCTB+5), Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052584585","display_name":"Belete Ayele Desimmie","orcid":"https://orcid.org/0000-0002-1157-4224","observed_orcids":["https://orcid.org/0000-0002-1157-4224"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Belete A. Desimmie","raw_affiliation_strings":["Katholieke Universiteit Leuven, Molecular Virology and Gene Therapy (VCTB+5), Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Katholieke Universiteit Leuven, Molecular Virology and Gene Therapy (VCTB+5), Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042297563","display_name":"Arnaud Marchand","orcid":"https://orcid.org/0000-0002-0007-382X","observed_orcids":["https://orcid.org/0000-0002-0007-382X"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Arnaud Marchand","raw_affiliation_strings":["CISTIM, CISTIM Leuven Vzw, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CISTIM, CISTIM Leuven Vzw, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110970418","display_name":"Scott Butler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189718659","display_name":"Pfizer (United Kingdom)","ror":"https://ror.org/04x4v8p40","country_code":"GB","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I189718659"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Scott Butler","raw_affiliation_strings":["Pfizer Ltd., Sandwich, Kent, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Ltd., Sandwich, Kent, United Kingdom","institution_ids":["https://openalex.org/I189718659"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026094812","display_name":"Wim J. Smets","orcid":"https://orcid.org/0009-0004-0598-3226","observed_orcids":["https://orcid.org/0009-0004-0598-3226"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Wim Smets","raw_affiliation_strings":["CISTIM, CISTIM Leuven Vzw, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CISTIM, CISTIM Leuven Vzw, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021441715","display_name":"Patrick Chaltin","orcid":"https://orcid.org/0000-0001-6692-5004","observed_orcids":["https://orcid.org/0000-0001-6692-5004"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Patrick Chaltin","raw_affiliation_strings":["CISTIM, CISTIM Leuven Vzw, Leuven, Belgium","Katholieke Universiteit Leuven, Molecular Virology and Gene Therapy (VCTB+5), Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CISTIM, CISTIM Leuven Vzw, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]},{"raw_affiliation_string":"Katholieke Universiteit Leuven, Molecular Virology and Gene Therapy (VCTB+5), Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084731018","display_name":"Mike Westby","orcid":"https://orcid.org/0009-0000-2612-6689","observed_orcids":["https://orcid.org/0009-0000-2612-6689"]},"institutions":[{"id":"https://openalex.org/I189718659","display_name":"Pfizer (United Kingdom)","ror":"https://ror.org/04x4v8p40","country_code":"GB","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I189718659"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mike Westby","raw_affiliation_strings":["Pfizer Ltd., Sandwich, Kent, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Ltd., Sandwich, Kent, United Kingdom","institution_ids":["https://openalex.org/I189718659"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044112097","display_name":"Zeger Debyser","orcid":"https://orcid.org/0000-0002-3982-1565","observed_orcids":["https://orcid.org/0000-0002-3982-1565","https://orcid.org/0000-0003-0849-8715"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Zeger Debyser","raw_affiliation_strings":["Katholieke Universiteit Leuven, Molecular Virology and Gene Therapy (VCTB+5), Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Katholieke Universiteit Leuven, Molecular Virology and Gene Therapy (VCTB+5), Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069500944","display_name":"Chris Pickford","orcid":"https://orcid.org/0009-0008-6600-8132","observed_orcids":["https://orcid.org/0009-0008-6600-8132"]},"institutions":[{"id":"https://openalex.org/I189718659","display_name":"Pfizer (United Kingdom)","ror":"https://ror.org/04x4v8p40","country_code":"GB","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I189718659"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Chris Pickford","raw_affiliation_strings":["Pfizer Ltd., Sandwich, Kent, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Ltd., Sandwich, Kent, United Kingdom","institution_ids":["https://openalex.org/I189718659"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5069500944"],"corresponding_institution_ids":["https://openalex.org/I189718659"],"apc_list":null,"apc_paid":null,"fwci":15.2266,"has_fulltext":false,"cited_by_count":197,"citation_normalized_percentile":{"value":0.99523788,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"56","issue":"8","first_page":"4365","last_page":"4374"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-integrase","display_name":"HIV integrase","score":0.8410000205039978},{"id":"https://openalex.org/keywords/ledgf-p75","display_name":"LEDGF/p75","score":0.8320000171661377},{"id":"https://openalex.org/keywords/allosteric-inhibitors","display_name":"allosteric inhibitors","score":0.7829999923706055},{"id":"https://openalex.org/keywords/integrase-multimerization","display_name":"integrase multimerization","score":0.8930000066757202},{"id":"https://openalex.org/keywords/raltegravir","display_name":"raltegravir","score":0.9100000262260437},{"id":"https://openalex.org/keywords/integrase-strand-transfer-inhibitors","display_name":"integrase strand transfer inhibitors","score":0.8130000233650208},{"id":"https://openalex.org/keywords/cross-resistance","display_name":"cross-resistance","score":0.7319999933242798},{"id":"https://openalex.org/keywords/hiv-replication","display_name":"HIV replication","score":0.5479999780654907},{"id":"https://openalex.org/keywords/integrase-inhibitors","display_name":"integrase inhibitors","score":0.48899999260902405}],"concepts":[{"id":"https://openalex.org/C14430832","wikidata":"https://www.wikidata.org/wiki/Q412550","display_name":"Integrase","level":3,"score":0.9664139747619629},{"id":"https://openalex.org/C166342909","wikidata":"https://www.wikidata.org/wiki/Q845326","display_name":"Allosteric regulation","level":3,"score":0.8921160697937012},{"id":"https://openalex.org/C2780404665","wikidata":"https://www.wikidata.org/wiki/Q421552","display_name":"Raltegravir","level":5,"score":0.7537704706192017},{"id":"https://openalex.org/C2777302000","wikidata":"https://www.wikidata.org/wiki/Q412251","display_name":"Integrase inhibitor","level":5,"score":0.6173056364059448},{"id":"https://openalex.org/C161624437","wikidata":"https://www.wikidata.org/wiki/Q1988322","display_name":"Small molecule","level":2,"score":0.539499044418335},{"id":"https://openalex.org/C140704245","wikidata":"https://www.wikidata.org/wiki/Q3933202","display_name":"Viral replication","level":3,"score":0.5276003479957581},{"id":"https://openalex.org/C107824862","wikidata":"https://www.wikidata.org/wiki/Q616005","display_name":"Binding site","level":2,"score":0.4854143559932709},{"id":"https://openalex.org/C121587506","wikidata":"https://www.wikidata.org/wiki/Q6888113","display_name":"Mode of action","level":2,"score":0.4647831916809082},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4403754770755768},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.43415483832359314},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4201374053955078},{"id":"https://openalex.org/C2776120743","wikidata":"https://www.wikidata.org/wiki/Q3271540","display_name":"Mechanism of action","level":3,"score":0.4150625467300415},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3272881507873535},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.32444316148757935},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.26615121960639954},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.20254084467887878},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.19260534644126892},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.12416568398475647},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.07580208778381348},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.07567998766899109}],"mesh":[{"descriptor_ui":"D000068898","descriptor_name":"Raltegravir Potassium","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001665","descriptor_name":"Binding Sites","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011760","descriptor_name":"Pyrrolidinones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D014779","descriptor_name":"Virus Replication","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D016662","descriptor_name":"Virus Integration","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D019427","descriptor_name":"HIV Integrase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D019427","descriptor_name":"HIV Integrase","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D019428","descriptor_name":"HIV Integrase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019428","descriptor_name":"HIV Integrase Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D020134","descriptor_name":"Catalytic Domain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D036341","descriptor_name":"Intercellular Signaling Peptides and Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D055503","descriptor_name":"Protein Multimerization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1128/aac.00717-12","doi":"https://doi.org/10.1128/aac.00717-12","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.00717-12","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2559966","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/articles/PMC3421592","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmid:22664975","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22664975","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial agents and chemotherapy","raw_type":"Journal Article"},{"id":"pmh:oai:lirias2repo.kuleuven.be:123456789/349511","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22664975","pdf_url":null,"source":{"id":"https://openalex.org/S7407055369","display_name":"Lirias","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy, vol. 56 (8), (4365-4374)","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3421592","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3421592/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.919.698","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.919.698","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://aac.asm.org/content/56/8/4365.full.pdf","raw_type":"text"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:2559966","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/articles/PMC3421592","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":53,"referenced_works":["https://openalex.org/W175056559","https://openalex.org/W1659719610","https://openalex.org/W1964170347","https://openalex.org/W1964423038","https://openalex.org/W1966515818","https://openalex.org/W1966539971","https://openalex.org/W1980365766","https://openalex.org/W1980869599","https://openalex.org/W1985711767","https://openalex.org/W1988176508","https://openalex.org/W1993363443","https://openalex.org/W1999403126","https://openalex.org/W2000106654","https://openalex.org/W2025344323","https://openalex.org/W2026732992","https://openalex.org/W2028179886","https://openalex.org/W2033637003","https://openalex.org/W2033964251","https://openalex.org/W2038070445","https://openalex.org/W2057675314","https://openalex.org/W2059772834","https://openalex.org/W2060221058","https://openalex.org/W2063825413","https://openalex.org/W2067786897","https://openalex.org/W2068095506","https://openalex.org/W2078247064","https://openalex.org/W2080086650","https://openalex.org/W2085489729","https://openalex.org/W2085992210","https://openalex.org/W2094076578","https://openalex.org/W2104029568","https://openalex.org/W2106494657","https://openalex.org/W2111556256","https://openalex.org/W2114137926","https://openalex.org/W2123025266","https://openalex.org/W2123317697","https://openalex.org/W2126391063","https://openalex.org/W2127621626","https://openalex.org/W2131570979","https://openalex.org/W2137646827","https://openalex.org/W2140356633","https://openalex.org/W2148026374","https://openalex.org/W2148291080","https://openalex.org/W2154190260","https://openalex.org/W2156432090","https://openalex.org/W2159775657","https://openalex.org/W2169976205","https://openalex.org/W2188299120","https://openalex.org/W2482172194","https://openalex.org/W2506068320","https://openalex.org/W3145408932","https://openalex.org/W4238923930","https://openalex.org/W4255147463"],"related_works":["https://openalex.org/W2124484151","https://openalex.org/W2010499706","https://openalex.org/W1985711767","https://openalex.org/W2150698261","https://openalex.org/W1968482088","https://openalex.org/W2523563370","https://openalex.org/W2169976205","https://openalex.org/W4380422708","https://openalex.org/W7066517193","https://openalex.org/W2129084136"],"abstract_inverted_index":{"Targeting":[0],"the":[1,20,43,58,92,100,108,118,164,180],"HIV":[2,33,48,143,169],"integrase":[3,131],"(HIV":[4],"IN)":[5],"is":[6,123],"a":[7,23,36,82,140,147],"clinically":[8,165],"validated":[9],"approach":[10],"for":[11],"designing":[12],"novel":[13,24,69],"anti-HIV":[14],"therapies.":[15],"We":[16],"have":[17],"previously":[18],"described":[19],"discovery":[21],"of":[22,26,47,61,64,68,111,121,150,156,183,185,192,205],"class":[25],"integration":[27,144],"inhibitors,":[28,88],"2-(quinolin-3-yl)acetic":[29],"acid":[30],"derivatives,":[31],"blocking":[32,99],"replication":[34,148],"at":[35],"low":[37],"micromolar":[38],"concentration":[39],"through":[40],"binding":[41,45,94],"in":[42,96,139,142,146,161,201],"LEDGF/p75":[44,93,103],"pocket":[46,95],"integrase,":[49,97],"hence":[50],"referred":[51],"to":[52,91,159],"as":[53],"LEDGINs.":[54,206],"Here":[55],"we":[56],"report":[57],"detailed":[59],"characterization":[60],"their":[62],"mode":[63,120,182],"action.":[65],"The":[66,133,153,189],"design":[67],"and":[70,81,104,145,176,187,194],"more":[71],"potent":[72],"analogues":[73],"with":[74,102,107,163,196],"nanomolar":[75],"activity":[76,110],"enabled":[77],"full":[78],"virological":[79],"evaluation":[80],"profound":[83],"mechanistic":[84],"study.":[85],"As":[86],"allosteric":[87,119,154,190],"LEDGINs":[89,137,157,186],"bind":[90],"thereby":[98],"interaction":[101],"interfering":[105],"indirectly":[106],"catalytic":[109],"integrase.":[112],"Detailed":[113],"mechanism-of-action":[114],"studies":[115],"reveal":[116],"that":[117],"inhibition":[122,135,193],"likely":[124],"caused":[125],"by":[126,136],"an":[127,199],"effect":[128],"on":[129],"HIV-1":[130],"oligomerization.":[132],"multimodal":[134],"results":[138],"block":[141],"deficiency":[149],"progeny":[151],"virus.":[152],"nature":[155,191],"leads":[158],"synergy":[160],"combination":[162],"approved":[166],"active":[167],"site":[168],"IN":[170],"strand":[171],"transfer":[172],"inhibitor":[173],"(INSTI)":[174],"raltegravir,":[175],"cross-resistance":[177],"profiling":[178],"proves":[179],"distinct":[181],"action":[184],"INSTIs.":[188],"compatibility":[195],"INSTIs":[197],"underline":[198],"interest":[200],"further":[202],"(clinical)":[203],"development":[204]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2099475302","counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":14},{"year":2021,"cited_by_count":12},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":14},{"year":2018,"cited_by_count":12},{"year":2017,"cited_by_count":11},{"year":2016,"cited_by_count":17},{"year":2015,"cited_by_count":15},{"year":2014,"cited_by_count":28},{"year":2013,"cited_by_count":25},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
